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Abstract
The prevalence of chronic obstructive pulmonary disease among patients with cardio-vascular diseases is higher than 
in general population. At the same time the one of problems of internal medicine is a timely diagnostics of chronic obstructive 
pulmonary disease. 
The aim of the work was the study of prevalence of chronic obstructive pulmonary disease among patients with cardio-vas-
cular diseases, especially arterial hypertension and coronary heart disease. 
Materials and methods. The retrospective analysis of statistical cards of patients, who were on stationary treatment at thera-
peutic departments, was carried out to estimate the prevalence of combination of chronic obstructive pulmonary disease with arterial 
hypertension. The target examination of 136 patients was realized for revelation of chronic obstructive pulmonary disease. All pa-
tients were interrogated by the original modified questionnaire of assessment of short breath by medical research council (mMRC), 
test for assessment of chronic obstructive pulmonary disease (CAT) and underwent spirography with bronchodilatation test. 
Results. It was established, that 10,2 % of patients had the combination of chronic obstructive pulmonary disease with arte-
rial hypertension. Among persons, who were on treatment as to the stable coronary heart disease and had not obstructive disease of 
respiratory organs in anamnesis, in 26,4 % the chronic obstructive pulmonary disease was diagnosed for the first time. 
Keywords: chronic obstructive pulmonary disease, comorbid pathology, arterial hypertension, coronary heart disease, 
diagnostics. 
DOI: 10.21303/2504-5679.2017.00320 © Lesya Rasputina, Daria Didenko
1. Introduction
The disease of respiratory organs and the ones of cardio-vascular system are often destined 
for co-existence. They often start at the same age, have common proved risk factors, series of 
similar pathophysiological mechanisms, namely: chronic hypoxia, rheological changes of blood 
and so on. It must be noted that essential ageing of the planet population resulted in increase of the 
number of persons, who have chronic diseases of respiratory organs, including chronic obstructive 
pulmonary disease and cardio-vascular diseases, first of all, arterial hypertension and coronary 
heart disease [1–3].
The prevalence of chronic obstructive pulmonary disease in the world among men and wom-
en is 9,3 % and 7,3 %, among smokers – 26,2 and 23,7 %, respectively [4, 5]. The meta-analysis 
of series of randomized studies established that the prevalence of chronic obstructive pulmonary 
disease in the world and Europe is on average 7,2 %, that is near four million and hundred people 
suffer from this disease, in city dwellers the prevalence of chronic obstructive pulmonary disease 
reaches 10,2 %, among men – 9,8 % and women – 5,6 % respectively, among patients, older than 
40 years – 10 %, older than 65 years – 14,2 %, among smokers – 15,4 %, among persons, who never 
smoked – 4,3 %, among persons, who left smoking – 10,7 % [4, 6, 7]. 
The important factor that conditions the urgency of problem of chronic obstructive pulmo-
nary disease is the high cost of this pathology for health protection system and society in whole. 
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According to the data of Global Initiative for Chronic Obstructive Lung Disease (GOLD), in Eu-
ropean countries the annual direct expenditures for chronic obstructive pulmonary disease reach 
38,6 billion dollars and indirect ones exceed 17 billion dollars [4].
At the same time the tendency to growth of the number of patients with cardio-vascular dis-
eases, especially, arterial hypertension that is the one of main causes of morbidity and invalidism of 
population as a result of its prevalence, is observed in the world. Arterial hypertension is registered 
with frequency 15–20 % among adult population of the world and 30–60 % among patients of elder 
age group [8, 9]. Arterial hypertension is an important risk factor of development of complication 
in cardio-vascular system, injury of target organs that determines morbidity and early invalidism 
of patients [10, 11]. 
In Ukraine there are almost 12 million persons with arterial hypertension and only 14 % of 
them control the level of arterial pressure (AP) [12]. 
The scientists and doctors throughout the world deal with the problem of combination of 
chronic obstructive pulmonary disease and cardio-vascular system diseases. Thus, the ten-year 
retrospective analysis of the medical cards of stationary patients revealed that in 51,7 % of pa-
tients with chronic obstructive pulmonary disease was diagnosed the diseases of cardio-vascular 
system, most frequent among them were coronary heart disease – in 28,9 % , heart failure – in 
19,6 %, rhythm disorder – in 12,6 % [1, 13, 14]. The frequency of concomitant cardio-vascular 
disorders increased with age and had the close connection with sex, there was observed the 
increase of the number of men with combination of chronic obstructive pulmonary disease and 
coronary heart disease. At combined clinical course of chronic obstructive pulmonary disease 
and concomitant CVD the frequency of hospitalization increased because of any diseases during 
the year [6, 15].
Some scientists consider chronic obstructive pulmonary disease as an independent risk 
factor of cardio-vascular complications [16]. Among patients with chronic obstructive pulmonary 
disease the prevalence of heart failure is 2 times more, stable angina 2,5 times more, peripheral 
vessels diseases 2,4 more, stroke 1,5 times more comparing with general population [17, 18]. So the 
problem of diagnostic of chronic obstructive pulmonary disease in patients with arterial hyperten-
sion and coronary heart disease is today urgent and rather difficult that determines the topicality 
of our studies. 
2. Aim of research
Estimation of the prevalence of chronic obstructive pulmonary disease among patients with 
coronary heart disease and arterial hypertension, who visited health protection institutions for 
medical help. 
3. Materials and methods
The study was carried out in three stages. At the first stage the retrospective analysis 
of 15 134 statistical medical cards of patients, who were on stationary treatment at therapeutic 
departments of the clinical hospital № 1 of Vinnytsia city during the period 2007–2009 were 
studied.
The other stage of the work was carried out in 2016 year. There was carried out the target 
diagnostics of chronic obstructive pulmonary disease of persons, who were on treatment at car-
diologic department in 2016 for stable coronary heart disease and had not obstructive diseases 
of respiratory organs in anamnesis. The group of examination included 136 patients, mean age 
(61,6±1,02) years, men – 109 (80,1 %), women – 27 (19,9 %). The diagnosis of coronary heart dis-
ease, verified by the results of coronography was in 78 (57,3 %) patients, by anamnesis data as to 
Q-myocardium infarction in 105 (77,2 %) patients, surgical interventions as myocardium revas-
cularization in anamnesis were observed in 57 (41,9 %)patients, including stenting of coronary 
arteries – 42 (30,8 %) patients, aortacoronary bypass – 15 (11 %) patients. Smoking was indicated 
by 79 (58 %) patients, smoking index among smokers (24,5±2,9) packet/years. The complicated 
professional anamnesis was in 33 (24,2 %) patients (Table 1).
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Characteristic of examined persons 
Parameter (n=136) Results
Number of patients 136
Mean age, years 61,6±1,02
Men, abs., (%) 109 (80,1 %)
Women, abs., (%) 27 (19,9 %)
Post-infarction cardiosclerosis, abs., (%) 105 (77,9 %)
Stable exertional angina, ІІ functional class, abs., (%) 48 (35,3 %)
Stable exertional angina, ІIІ functional class, abs., (%) 85 (62,5 %)
Coronography, abs., (%) 78 (57,3 %)
Stenting of coronary arteries, abs., (%) 42 (30,8 %)
ACS, abs., (%) 15 (11 %)
Hypertonic disease, abs., (%) 116 (87,2 %)
Heart failure, I functional class, abs., (%) 5 (3,6 %)
Heart failure, II functional class, abs., (%) 103 (75,7 %)
Heart failure, III functional class, abs., (%) 25 (18,3 %)
Diabetes mellitus, abs., (%) 20 (14,7 %)
Obesity, abs., (%) 55 (40,4 %)
Smoking, abs., (%) 79 (58 %)
Complicated professional anamnesis, abs., (%) 33 (24,2 %)
Complicated hereditary anamnesis as to chronic obstructive pulmonary disease, abs., (%) 5 (3,7 %)
Complicated hereditary anamnesis as to coronary heart disease, abs., (%) 26 (19,1 %)
All patients, included in the study at the second stage of the work (n=136), were interrogated 
by original questionnaire, created on the base of GOLD 2015 recommendations for diagnostics of 
chronic obstructive pulmonary disease [4] (Table 2).
Table 2
Questionnaire for diagnostics of chronic obstructive pulmonary disease 
Question questionnaire Positive response Negative response
Do you have permanent cough several times a day? Yes No
Do you cough up sputum every day? Yes No
Do you have short breath more often than your coevals? Yes No
Your age is more than 40 years? Yes No
Do you smoke or smoked in past? Yes No
The patients also underwent computer spirography with bronchodilatation test using 
400 mcg of salbutamol (MasterScope ST) and interrogation by modified questionnaire of short 
breath assessment of medical research council (mMRC) and test of chronic obstructive pulmonary 
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disease (CAT) for determination of clinical group of chronic obstructive pulmonary disease, regu-
lated by the order by HPM of Ukraine № 555 of 27.05.2013 and GOLD recommendations.
Statistical processing of the data was carried out using the package of statistical programs 
STATISTICA10.0 and MicrosoftExel. The reliability of difference of values was calculated by 
non-parametric method by χ² Pearson’s criterion, U-test by Mann-Whitney and Student t-criterion 
at comparison of mean values. 
4. Results of research
According to the results of the first retrospective stage of the work, it was established, that in 
period 2007–2009 at therapeutic departments of the hospital were treated 15134 patients, (8775 men 
(57,9 %) and 6359 women (42,1 %)). Among all patients 1538 patients with chronic obstructive 
pulmonary disease 10,2 % had concomitant arterial hypertension. Among men the prevalence of 
combination of chronic obstructive pulmonary disease with arterial hypertension was diagnosed in 
880 patients (10,02 %), among women – in 658 (10,4 %).
Fig. 1. Part of patients, treated at therapeutic departments of MCH № 1  
during the period 2007–2009, and had combination of chronic obstructive pulmonary disease and 
concomitant arterial hypertension
The stable tendency to growth of the number of patients with combined pathology is ob-
served annually. The growth of part of patients with polymorbid pathology has progressive charac-
ter. Thus, in 2007 it was 8,17 %, in 2008 – 10,9 %, in 2009 – 12,42 % (Fig. 2).
Fig. 2. Prevalence of combination of chronic obstructive pulmonary disease and  
cardio-vascular diseases at therapeutic departments of municipal hospital 
There is observed certain tendency as to distribution of chronic obstructive pulmonary dis-
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Prevalence of combined course of chronic obstructive pulmonary 
disease and arterial hypertension 
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with such combination was more among women than among men. Whereas in 2008 and 2009 men 
prevailed, that has a tendency to growth.
Fig. 3. Frequency of combination of chronic obstructive pulmonary disease and  
arterial hypertension at therapeutic departments of municipal hospital among men and  
women during the period 2007–2009 
Most patients with comorbid pathology were hospitalized at pulmonological department, 
especially 1051 (68,3 %) persons, whereas at cardiologic one were 326 patients (21,2 %) and at 
therapeutic one – 161 persons (10,5 %).
According to the results of second stage of questionnaire work, it was established, that the 
positive answers to the questions of the questionnaire were given by all 136 patients with stable 
coronary heart disease. Among the interrogated patients 3 (2,2 %) gave the positive answer to 
only 1 question, 50 (36,7 %) persons – to 2 questions, 61 (44,9 %) – to 3 questions, 17 (12,5 %) 
patients –  o 4 questions and 5 (3,7 %) persons – to all 5 questions of the questionnaire, respec-
tively. It must be noted that 80 (58,8 %) interrogated persons gave the positive answer to 3 and 
more questions, so they have clinical symptoms, typical for combination of chronic obstructive 
pulmonary disease. 
All patients underwent spirometry with bronchodilitation test. According to its results, com-
bination of chronic obstructive pulmonary disease was diagnosed in 36 (26,4 %) patients with 
stable coronary heart disease, mean age (62±1,9) years (Fig. 4). 
Fig. 4. Frequency of revelation of chronic obstructive pulmonary disease among patients with 
stable coronary heart disease, n=136
We analyzed two groups of patients, І included 36 persons with coronary heart disease with 
concomitant chronic obstructive pulmonary disease and ІІ included 100 persons with coronary 
heart disease without diagnosed chronic obstructive pulmonary disease. Although the patients of 
both groups were of the same age, there is observed the tendency to most frequent manifestation 
of chronic obstructive pulmonary disease among men (91,7 % and 76 % respectively, р=0,07), who 
had more severe functional class of angina (69,4 % and 61 %, p=0,12), reliably more often after 
aortocoronary bypass (22,2 % and 7 %, р=0,04) and had heart failure of III functional class (30,6 % 
and 14 %, р=0,03). The diagnosis of heart failure of III functional class in patients of this category 
can be explained by underestimation of the symptoms of chronic obstructive pulmonary disease, 
 
74,6 % 
26,4 % Patients with coronary heart
disease, n=100, mean age
(61,2±1,2) years
Patients with coronary heart
disease and chronic obstructive
pulmonary disease, n=36, mean
age  (62±1,9) years
Original Research Article:
full paper




because short breath was assessed by doctors as a sign of heart failure. Among patients of І group 
comparing with two group was observed the tendency to more frequency of other concomitant dis-
eases, namely hypertonic disease (88,9 % and 84 % respectively, р=0,22), diabetes mellitus (25 % 
and 11 %, р=0,06),obesity (47,2 % and 38 %, р=0,08) (Table 3).
Table 3
Characteristic of patients with stable coronary heart disease and concomitant chronic obstructive pulmonary 
disease and patients with stable coronary heart disease without concomitant chronic obstructive pulmonary disease 
Characteristic
І group patients with stable coronary 
heart disease and concomitant chronic 
obstructive pulmonary disease, n=36
ІІ group patients with 
stable coronary heart 
disease n=100
Mean age, years 62±1,9 61,2±1,2
Men, abs., (%) 33 (91,7 %) 76 (76 %)
Women, abs., (%) 3 (8,3 %) 21 (21 %)
Post-infarction cardiosclerosis, abs., (%) 26 (72,2 %) 79 (79 %)
Stable exertional angina, ІІ functional class, abs., (%) 11 (30,5 %) 37 (37 %)
Stable exertional angina, ІIІ functional class, abs., (%) 25 (69,4 %)* 60 (60 %)*
Coronography, abs., (%) 17 (47,2 %) 61 (61 %)
Stenting of coronary arteries, abs., (%) 8 (22,2 %) 34 (34 %)
ACS, abs., (%) 8 (22,2 %)* 7 (7 %)*
Hypertonic disease, abs., (%) 32 (88,9 %) 84 (84 %)
Heart failure, I functional class, abs., (%) 0 5 (5 %)
Heart failure, II functional class, abs., (%) 25 (69,4 %) 78 (78 %)
Heart failure, III functional class, abs., (%) 11 (30,6 %) 14 (14 %)
Diabetes mellitus, abs., (%) 9 (25 %) 11 (11 %)
Obesity, abs., (%) 17 (47,2 %) 38 (38 %)
Smoking, abs., (%) 27 (75 %) 51 (51 %)
Note: * − difference between groups is reliable, р<0,05, calculation was carried out using Pearson χ² criterion
Patients with coronary heart disease and firstly diagnosed chronic obstructive pulmonary 
disease were distributed by the clinical groups of chronic obstructive pulmonary disease. Among 
36 patients with stable coronary heart disease and chronic obstructive pulmonary disease 9 (25 %) 
patients were included in the group A, that is the patients with metasymptom course and low risk of 
complications, 17 (47,2 %) patients - in group B that is the patients with many symptoms of chron-
ic obstructive pulmonary disease and low risk of complications, 2 (5,6 %) patients – in group C, 
who have little number of symptoms and high risk of complications, 8 (22,2 %) patients formed 
D group, they had many clinical symptoms of chronic obstructive pulmonary disease and high risk 
of complications. 
5. Discussion of results
The analysis revealed the essential layer of patients, who had combination of chronic ob-
structive pulmonary disease and stable coronary heart disease and arterial hypertension. Such 
comorbidity is noted by the scientists of different countries. It can be explained by the series of fac-
tors, namely: essential ageing of population, spreading of risk factors, influence of professional and 
everyday factors [12, 14, 19]. The same factors play the essential role in formation of cardio-vascu-
lar diseases. At the same time it must be noted that the concrete data as to the prevalence of chronic 
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obstructive pulmonary disease in patients with cardio-vascular diseases are absent. Thus, the prev-
alence of arterial hypertension in persons with chronic obstructive pulmonary disease varies from 
16 to 75 % according to the data of different scientists [17, 19].
The complications of diagnostics of these combined diseases appear as a result of late resort 
to medical help, little number of symptoms at early stages of disease. It must be also noted that pa-
tients’ complaints are often considered by doctors as manifestations of other diseases, for example, 
heart failure but not of chronic obstructive pulmonary disease.
Despite the stereotype literary data about the prevalence of men among patients with com-
bined clinical course, we established the tendency to the growth of women number with cardio-vas-
cular pathology at the background of chronic obstructive pulmonary disease. Especially, the prev-
alence of combined course among men and women in 2007 was 7,39 % and 9,35 % respectively, in 
2008 – 11,2 % and 10,7 % respectively, in 2009 – 12,7 % and 10,9 % respectively [11].
The special complications take place in diagnostics of chronic obstructive pulmonary dis-
ease in patients with stable coronary heart disease, because in this group of patients the use of 
functional methods of examination, especially spirography with broncholithus is limited. This very 
point of view is shared by doctors of general practice. It is argued by the data about the influence 
of broncholithus on heart rate, electrolytic changes. So, it is important to elaborate the simple avail-
able screening methods that allow to select patients for further functional examination with high 
reliability degree [11, 20–22]. This very aim is set in our work. 
It is worth attention, that in all patients, who gave 4 or 5 positive answers to the questions of 
the questionnaire, chronic obstructive pulmonary disease was diagnosed after examination of the 
function of external breath that testifies to the possibility of using this questionnaire to select pa-
tients with coronary heart disease for spirometry that is expedient for timely diagnostics of chronic 
obstructive pulmonary disease. Undoubtedly, our research is today limited only by retrospective 
analysis and examination of the small group of patients with stable coronary heart disease. Our 
further observations and studies will allow widen the data as to the features of course of chronic 
obstructive pulmonary disease in different categories of patients. 
6. Conclusions
1. Thus, there is a numerous general therapeutic group of patients with diagnosed combina-
tion of chronic obstructive pulmonary disease with arterial hypertension, namely – 10,2 %.
2. According to the data of retrospective analysis, there is observed the progressive growth 
of the number of persons with combined pathology, namely chronic obstructive pulmonary disease 
with arterial hypertension from 2007 to 2009 year from 8,17 % to 12,42 %. These patients visit a 
pulmonologist most often.
3. Chronic obstructive pulmonary disease was diagnosed in 36 (26,4 %) patients after the 
target diagnostics among ones with stable coronary heart disease, who had not obstructive diseases 
of respiratory organs in anamnesis. 
4. It was noted, that chronic obstructive pulmonary disease of A and B groups that had the low 
level of unfavorable events development was diagnosed in 26 (72,2 %) patients and in 10 (27,8 %) – C 
and D groups, associated with the high risk of unfavorable changes and complications. 
5. In the group of patients with previously non-diagnosed chronic obstructive pulmonary 
disease prevail men (91,7 %), smokers (75 %) with other concomitant diseases, especially arterial 
hypertension (88,9 %), obesity (47,2 %), diabetes mellitus (25 %).
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